Cancer targeting and drug delivery using carbon-based quantum dots and nanotubes

Joel Pardo, Zhili Peng, Roger Leblanc

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Currently cancer treatment is in large part non-specific with respect to treatment. Medication is often harsh on patients, whereby they suffer several undesired side effects as a result. Carbon-based nanoparticles have attracted attention in recent years due to their ability to act as a platform for the attachment of several drugs and/or ligands. Relatively simple models are often used in cancer research, wherein carbon nanoparticles are conjugated to a ligand that is specific to an overexpressed receptor for imaging and drug delivery in cancer treatment. These carbon nanoparticles confer unique properties to the imaging or delivery vehicle due to their nontoxic nature and their high fluorescence qualities. Chief among the ongoing research within carbon-based nanoparticles emerge carbon dots (C-dots) and carbon nanotubes (CNTs). In this review, the aforementioned carbon nanoparticles will be discussed in their use within doxorubicin and gemcitabine based drug delivery vehicles, as well as the ligand-mediated receptor specific targeted therapy. Further directions of research in current field are also discussed.

Original languageEnglish (US)
Article number378
JournalMolecules
Volume23
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Nanotubes
Quantum Dots
Drug Delivery Systems
Drug delivery
Semiconductor quantum dots
nanotubes
delivery
drugs
Carbon
Nanoparticles
cancer
quantum dots
carbon
nanoparticles
Neoplasms
Oncology
gemcitabine
Ligands
ligands
vehicles

Keywords

  • Carbon dots
  • Carbon nanotubes
  • Doxorubicin
  • Drug delivery
  • Folic acid
  • Gemcitabine
  • Hyaluronan
  • Transferrin

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Cancer targeting and drug delivery using carbon-based quantum dots and nanotubes. / Pardo, Joel; Peng, Zhili; Leblanc, Roger.

In: Molecules, Vol. 23, No. 2, 378, 01.01.2018.

Research output: Contribution to journalReview article

@article{bec538e79146406eb39dbb92923675a7,
title = "Cancer targeting and drug delivery using carbon-based quantum dots and nanotubes",
abstract = "Currently cancer treatment is in large part non-specific with respect to treatment. Medication is often harsh on patients, whereby they suffer several undesired side effects as a result. Carbon-based nanoparticles have attracted attention in recent years due to their ability to act as a platform for the attachment of several drugs and/or ligands. Relatively simple models are often used in cancer research, wherein carbon nanoparticles are conjugated to a ligand that is specific to an overexpressed receptor for imaging and drug delivery in cancer treatment. These carbon nanoparticles confer unique properties to the imaging or delivery vehicle due to their nontoxic nature and their high fluorescence qualities. Chief among the ongoing research within carbon-based nanoparticles emerge carbon dots (C-dots) and carbon nanotubes (CNTs). In this review, the aforementioned carbon nanoparticles will be discussed in their use within doxorubicin and gemcitabine based drug delivery vehicles, as well as the ligand-mediated receptor specific targeted therapy. Further directions of research in current field are also discussed.",
keywords = "Carbon dots, Carbon nanotubes, Doxorubicin, Drug delivery, Folic acid, Gemcitabine, Hyaluronan, Transferrin",
author = "Joel Pardo and Zhili Peng and Roger Leblanc",
year = "2018",
month = "1",
day = "1",
doi = "10.3390/molecules23020378",
language = "English (US)",
volume = "23",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Cancer targeting and drug delivery using carbon-based quantum dots and nanotubes

AU - Pardo, Joel

AU - Peng, Zhili

AU - Leblanc, Roger

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Currently cancer treatment is in large part non-specific with respect to treatment. Medication is often harsh on patients, whereby they suffer several undesired side effects as a result. Carbon-based nanoparticles have attracted attention in recent years due to their ability to act as a platform for the attachment of several drugs and/or ligands. Relatively simple models are often used in cancer research, wherein carbon nanoparticles are conjugated to a ligand that is specific to an overexpressed receptor for imaging and drug delivery in cancer treatment. These carbon nanoparticles confer unique properties to the imaging or delivery vehicle due to their nontoxic nature and their high fluorescence qualities. Chief among the ongoing research within carbon-based nanoparticles emerge carbon dots (C-dots) and carbon nanotubes (CNTs). In this review, the aforementioned carbon nanoparticles will be discussed in their use within doxorubicin and gemcitabine based drug delivery vehicles, as well as the ligand-mediated receptor specific targeted therapy. Further directions of research in current field are also discussed.

AB - Currently cancer treatment is in large part non-specific with respect to treatment. Medication is often harsh on patients, whereby they suffer several undesired side effects as a result. Carbon-based nanoparticles have attracted attention in recent years due to their ability to act as a platform for the attachment of several drugs and/or ligands. Relatively simple models are often used in cancer research, wherein carbon nanoparticles are conjugated to a ligand that is specific to an overexpressed receptor for imaging and drug delivery in cancer treatment. These carbon nanoparticles confer unique properties to the imaging or delivery vehicle due to their nontoxic nature and their high fluorescence qualities. Chief among the ongoing research within carbon-based nanoparticles emerge carbon dots (C-dots) and carbon nanotubes (CNTs). In this review, the aforementioned carbon nanoparticles will be discussed in their use within doxorubicin and gemcitabine based drug delivery vehicles, as well as the ligand-mediated receptor specific targeted therapy. Further directions of research in current field are also discussed.

KW - Carbon dots

KW - Carbon nanotubes

KW - Doxorubicin

KW - Drug delivery

KW - Folic acid

KW - Gemcitabine

KW - Hyaluronan

KW - Transferrin

UR - http://www.scopus.com/inward/record.url?scp=85041928720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041928720&partnerID=8YFLogxK

U2 - 10.3390/molecules23020378

DO - 10.3390/molecules23020378

M3 - Review article

VL - 23

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 2

M1 - 378

ER -